[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Bexxar Treatment
Greetings from The 'Ville
I am soliciting experiences of those of you who may have had to keep a
Bexxar patient in your medical facility as an inpatient. Did you find
the I-131 labeled monoclonal antibody (I-131 Tositumomab) behaved much
differently than I-131 NaI? How did the room release go following
patient discharge? Thanks in advance for your contributions. -Dan
GO CARDS!
Danny K. McClung, RRPT
Health Physicist/Asst. RSO
********************
University of Louisville
Health Sciences Center
319 Abraham Flexner Way
Room 102, Building 55A
Louisville, KY 40202
502-852-6138 (phone)
502-852-8911 (fax)
************************************************************************
You are currently subscribed to the Radsafe mailing list. To
unsubscribe, send an e-mail to Majordomo@list.vanderbilt.edu Put the
text "unsubscribe radsafe" (no quote marks) in the body of the e-mail,
with no subject line. You can view the Radsafe archives at
http://www.vanderbilt.edu/radsafe/